TN
Tarun Nandkishor Sohinda
About Tarun Nandkishor Sohinda
Data last updated:
Tarun Nandkishor Sohinda is a Director at Tarun Biotech Private Limited (since 2020), Director at Nway Biotech Private Limited (since 2022) and Director at Pure Mint Pharma Private Limited (since 2025). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹13.01 Cr; the largest is Tarun Biotech Private Limited at ₹9.96 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Tarun Biotech Private Limited U24299MH2020PTC347436 | Director | 08 Oct 2020 | 2020 | ₹9.96 Cr (FY 2025) | Active |
 Nway Biotech Private Limited U21000MH2022PTC378142 | Director | 09 Mar 2022 | 2022 | ₹3.04 Cr (FY 2025) | Active |
| Pure Mint Pharma Private Limited U21000MH2025PTC459983 | Director | 30 Oct 2025 | 2025 | Active |
Board colleagues of Tarun Nandkishor Sohinda
| Name | DIN | Company | Designation |
|---|---|---|---|
| Nandkishor Chandraprakash Soohinda | 08909478 | Tarun Biotech Private Limited | Director |
| Viresh Rajesh Dasare | 06720313 | Nway Biotech Private Limited | Additional Director |
| Vishal Jawaharlal Bohra | 06995338 | Pure Mint Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Tarun Nandkishor Sohinda
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tarun Nandkishor Sohinda
Tarun Nandkishor Sohinda currently holds 3 directorships: Tarun Biotech Private Limited (Director, since 08 Oct 2020, revenue ₹9.96 Cr (FY 2025)); Nway Biotech Private Limited (Director, since 09 Mar 2022, revenue ₹3.04 Cr (FY 2025)); Pure Mint Pharma Private Limited (Director, since 30 Oct 2025).
Tarun Nandkishor Sohinda was first appointed on 08 Oct 2020 as Director at Tarun Biotech Private Limited. The most recent appointment on record is 30 Oct 2025 at Pure Mint Pharma Private Limited.
The 2 current companies of Tarun Nandkishor Sohinda that report revenue have a combined latest revenue of ₹13.01 Cr: Tarun Biotech Private Limited ₹9.96 Cr (FY 2025); Nway Biotech Private Limited ₹3.04 Cr (FY 2025).
The current boards of Tarun Nandkishor Sohinda's companies include Nandkishor Chandraprakash Soohinda (Tarun Biotech Private Limited), Viresh Rajesh Dasare (Nway Biotech Private Limited), Vishal Jawaharlal Bohra (Pure Mint Pharma Private Limited).